2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Kitay B, Murphy E, Macaluso M, Corlett P, Hershenberg R, Joormann J, Martinez-Kaigi V, Nikayin S, Rhee T, Sanacora G, Shelton R, Thase M, Wilkinson S. Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol. Psychiatry Research 2023, 330: 115585. PMID: 37935086, DOI: 10.1016/j.psychres.2023.115585.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMajor depressionSuicidal ideationRelapse preventionBehavioral therapyStudy protocolHigh riskClinical trial study protocolLong-term treatment approachKey secondary outcomesTrial study protocolHigh relapse rateHigh-risk populationSignificant suicidal ideationHospital dischargeSecondary outcomesPrimary outcomeRelapse rateFeasibility trialEsketamineTreatment approachesPatientsSuicide attemptsTherapySupplemental indications
2016
Depressive Symptoms After Critical Illness
Rabiee A, Nikayin S, Hashem MD, Huang M, Dinglas VD, Bienvenu OJ, Turnbull AE, Needham DM. Depressive Symptoms After Critical Illness. Critical Care Medicine 2016, 44: 1744-1753. PMID: 27153046, PMCID: PMC7418220, DOI: 10.1097/ccm.0000000000001811.Peer-Reviewed Original ResearchConceptsDepressive symptomsICU survivorsHospital AnxietyRisk factorsCochrane Controlled Trials RegistryDepression Scale depression subscaleImportant depressive symptomsControlled Trials RegistryDuplicate independent reviewAllied Health LiteratureCritical illnessHospital dischargeTrials RegistryPsychologic morbidityPooled changeCumulative IndexEligible articlesHealth LiteratureSymptomsNatural historyDistress symptomsPrevalenceThreshold scoreTime pointsMonths